Court battle expected over generic Plavix

08/11/2006 | San Diego Union-Tribune

Bristol-Myers Squibb this week is expected to seek an injunction to bar Canadian drugmaker Apotex from selling a generic version of the blood thinner Plavix. Bristol-Myers and its partner Sanofi-Aventis had a deal with Apotex to delay sales of the generic, but that agreement recently fell apart.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care